By slicing and dicing the data, the study confirms MITRA-FR as an outlier and emphasizes the need for careful patient selection.
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results